Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is frequently associated with type 2 diabetes. However, there is no specific medical therapy to treat this condition. Angiotensin‐converting enzyme 2 (ACE2) of the protective renin angiotensin system gener...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health/LWW
2022-05-01
|
| Col·lecció: | Hepatology Communications |
| Accés en línia: | https://doi.org/10.1002/hep4.1884 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|